Lignes directrices de l’accès et leurs indicateurs

The EPN Access to Essential Medicines guidelines do not address issues beyond the control of church health services (CHSs), such as foreign exchange rates, storage outside the CHS system, patient poverty, number of pharmaceutical staff (for example, pharmacists available), and patient information from other sources (for example, advertising). Nor do the guidelines address issues that are beyond the remit of EPN to assist CHSs, such as access to transport, construction of stores, the CHS system in its entirety, the expansion of CHSs to serve larger populations, and the health service of a country in general. These areas are recognized as being important but are nonetheless beyond the remit of this particular project.

Please download:

Also see:

The guideline approach

Three factors are fundamental to this approach:

  1. The initial baseline study for each country that reveals the current level of compliance on each of the specific guidelines and provides an impact assessment tool.
  2. The development of country-specific plans, owned by EPN members, to increase compliance in a specific country.
  3. The transfer of knowledge to members in other countries to increase their capacity to carry out such work.

The impact of individual guidelines is cumulative and there is no specific prioritization within them. However, for access to be maximized, it is believed that all the specifics detailed by the guidelines need to be in place. Each country will have its own pattern of compliance and the importance of interventions will depend on country specifics. It is believed that, as countries are at different levels of compliance, the priority for intervention to increase compliance should reflect local circumstances and not an external priority list. Thus, in any particular country, a small intervention may 'top up' a particular guideline activity and therefore may be prioritized over a large intervention targeting another recommended guideline from start-up to compliance. For example:

The key to developing country-specific plans is the results from the baseline survey. These results will not only allow impact evaluation and monitoring but also provide information for decision making. 

Guidelines and their indicators 

  1. Compliance with best practices for drug storage and management.
  2. Compliance with rational use of medicines guidelines.
  3. Functioning medical supply system.
  4. Functioning Drug and Therapeutics Committees (DTC) in hospitals.
  5. All 'owners' with maximum understanding or roles, best practice, and management information.
  6. Implementation of standard operating procedures for procurement.
  7. Improvement in access to medicines for a facility, passed on to patients.
  8. Quality assurance policy in place and implemented.
  9. Pricing policies in place and operationalized.
  10. Government subsidies extended.
  11. Pro-poor ethic in evidence.
  12. Tax exemptions available to CHSs.
  13. Transparency mechanisms in place in support of 'Health for All'.
  14. Effective community involvement system in place.
  15. Cross-facility information sharing.
  16. Compliance with drug donations guidelines.
  17. Mechanism in place to allow for representation at regional and national levels in relevant debates.
  18. At least one pharmaceutically trained person per facility.
  19. Access to key pharmaceutical information.
  20. Regular assessment of pharmaceutical unit work.
  21. Church leaders' awareness of key messages.
  22. Pharmaceutical function represented at all levels of discussion.
  23. Disaster preparedness procedures in place (e.g., earthquake, flood, influx of refugees, conflict).

Access guidelines baseline research

Malawi Access baseline survey

Access research feedback and next steps, Blantyre, Malawi

Uganda Access baseline survey

Ghana Access baseline survey